Sarah is Head of the Immunovirology and Pathogenesis Program and Scientia Senior Lecturer at The Kirby Institute UNSW as well as a Clinical Immunologist & Immunopathologist at NSW Health Pathology ICPMR Westmead Hospital. She graduated from a BSc(HonsI)/BA (English) prior to a combined MBBS(Hons)/PhD program. Sarah completed specialist medical training in Clinical Immunology and Immunopathology at St Vincent's, Royal Prince Alfred, Concord, Liverpool and Campbelltown Hospitals and gained dual fellowships of the Royal Australasian College of Physicians and Royal College of Pathologists Australasia in 2017.
Sarah's research involves applying contemporary tools of wet-laboratory research and bioinformatics to human diseases and vaccinology. She has an active research program investigating the immunology and pathogenesis of sepsis and the systemic inflammatory response syndrome (SIRS). Sarah is the Co-ordinating Chief Investigator of the Medical Research Future (MRFF)-Funded CIRCUIT study investigating optimal timing of COVID-19 booster vaccines in people commencing new immunosuppression.
Sarah leads projects in Cancer Immunology, including the investigation of host clearance of human papillomavirus (HPV)-driven malignancies and also Measurable Residual Disease (MRD) in hematological malignancies. From 2018-2019 Sarah undertook postdoctoral studies at the University of Oxford investigating autoimmune toxicities of immune checkpoint inhibitors in Professor Paul Klenerman's laboratory. Her postdoctoral work found CD8+ tissue resident memory T cells (TRMs) were a pathological hallmark of immune-checkpoint inhibitor-associated colitis and identified tofacitinib as a novel salvage therapy, findings that were published in Gastroenterology.
Sarah's PhD investigated interleuikin-7 (IL-7) signaling in the setting of HIV infection. She was a member of the Australian collaboration that defined a novel flow cytometry method for identifying regulatory T cells (Treg) as expressing CD25(bright) and lacking the IL-7 receptor CD127, published in the Journal of Experimental Medicine.
Sarah additionally works in the Medical Humanities, having published the international anthology Signs of Life (2021) and literary fiction novel Tidelines (2024). Sarah is a regular contributor to The Conversation.
Broad Research Areas:
Immunology, Infectious Diseases, Cancer Immunology, Immune Checkpoint Inhibitors, Mucosal Immunology, Sepsis
Qualifications:
BA, BSc(Hons I), MBBS(Hons), PhD, FRACP, FRCPA
Publications:
https://www.ncbi.nlm.nih.gov/myncbi/1limy-hBarikX/bibliography/public/